J&J offloads DePuy trauma unit to Biomet to smooth way for Synthes
This article was originally published in Clinica
Executive Summary
Biomet has swooped in to grab Johnson & Johnson's existing trauma business for $280m, a deal which should alleviate anti-trust issues in J&J's impending $21bn acquisition of trauma specialist Synthes.